About CenterVue
CenterVue is a company based in Padova (Italy) founded in 2008 by Giuliano Barbaro was acquired by Revenio Group in April 2019. CenterVue has raised $911 thousand across 1 funding round from investors including Revenio Group and Sofimac Investment Managers. CenterVue operates in a competitive market with competitors including Tobii Dynavox, NovaSight, Artiria, Oculogica and RetiSpec, among others.
- Headquarter Padova, Italy
- Founders Giuliano Barbaro
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$911 K (USD)
in 1 rounds
-
Latest Funding Round
$911 K (USD), Seed
Jun 01, 2011
-
Investors
Revenio Group
& 1 more
-
Employee Count
Not available
-
Acquired by
Revenio Group
(Apr 15, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CenterVue
CenterVue has successfully raised a total of $911K through 1 strategic funding round. The most recent funding activity was a Seed round of $911 thousand completed in June 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CenterVue
CenterVue has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Revenio Group and Sofimac Investment Managers.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Diagnostic devices for medical applications are developed and commercialized.
|
Locked | Locked | Locked |
Investor details for CenterVue
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CenterVue
Investment portfolio details for CenterVue
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CenterVue
Detailed financials for CenterVue
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Centervue Comparisons
Peer comparison for CenterVue
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CenterVue
CenterVue operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tobii Dynavox, NovaSight, Artiria, Oculogica and RetiSpec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Assistive communication solutions via eye-tracking are provided for differently-abled individuals.
|
|
| Locked | Locked | Locked |
Eye-tracking solutions for vision assessment and treatment are provided.
|
|
| Locked | Locked | Locked |
Micro-navigation systems for stroke surgery are developed.
|
|
| Locked | Locked | Locked |
Eye-tracking technology is utilized to detect traumatic brain injuries.
|
|
| Locked | Locked | Locked |
Non-invasive eye scanner for early Alzheimer’s detection is developed.
|
|
| Locked | Locked | Locked |
Eye-tracking devices are developed for neurodegenerative disease monitoring.
|
Detailed competitors of CenterVue
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Centervue
Complete news archive for CenterVue
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CenterVue
CenterVue was founded in 2008 and raised its 1st funding round 3 years after it was founded.
CenterVue is headquartered in Padova, Italy. It is registered at Padova, Veneto, Italy.
Giuliano Barbaro is the current CEO of CenterVue. They have also founded this company.
CenterVue is a funded company, having raised a total of $911K across 1 funding round to date.
CenterVue, a M31 alumnus, develops fundus imaging diagnostic devices for early detection of eye diseases such as Diabetic Retinopathy, Macular Degeneration and Glaucoma. Its products include the DRS whichis a traditional fundus camera, the Compass which is a Fundus Automated Perimeter that combines Visual Field measurement to TrueColor Confocal Imaging of the optic disc and RNFL, the Eidon is the a TrueColor Confocal Scanner that combines the advantages of SLO with the fidelity of true color fundus imaging, and the Maia device combines Images, Sensitivity and Fixation analysis for confocal microperimetry to assess macula integrity. Apart from these devices, Centervue also provides EKN which is an internet based software system, integrated with the DRS fundus camera and used to transmit retinal images and textual information, making them available for online consultation by authorized users, via the regular internet browser. CenterVue sells its products worldwide in more than 70 countries and a US subsidiary was started in 2010.
CenterVue's top competitors include NovaSight, RetiSpec and Tobii Dynavox.
CenterVue has 2 investors. Key investors include Revenio Group, and Sofimac Investment Managers.